|
Monday, March 24 — 11:00 AM — Maryland Suite
Click on the numbers in parentheses to display abstracts.
Section H2 - LIVER & PANCREAS PATHOLOGY
Chaired by: Robb Wilentz and N. Volkan Adsay
| 11:00 |
Cytokeratin 19 Is a Powerful Predictor of Survival in Pancreatic Endocrine Tumors
(1242)
V Deshpande, A Muzikansky, C Fernandez-del Castillo, GY Lauwers
Massachusetts General Hospital, Boston, MA
|
| 11:15 |
A Proposal for a New Grading Scheme for Pancreatic Ductal Adenocarcinoma (DA): Application of a Practical and Prognostically Relevant System Similar to Gleason Scoring
(1233)
NV Adsay, N Kilinc, M Bonnett, J Dey, JD Cheng, A Andea
Harper University Hospital; The Karmanos Cancer Institute; Wayne State University School of Medicine, Detroit, MI
|
| 11:30 |
Exploration of Highly Expressed Genes in Pancreatic Duct Adenocarcinomas Using U133 Oligonucleotide Arrays with Comparisons to Other Global Gene Expression Platforms
(1263)
CA Iacobuzio-Donahue, A Maitra, K Berg, MA Hollingsworth, SE Kern, MG Goggins, RH Hruban
The Johns Hopkins Hospital, Baltimore, MD; University of Nebraska, Omaha, NE
|
| 11:45 |
Differential Expression of Multiple Genes in Association with DPC4 Inactivation in Pancreatic Cancer
(1238)
Cao, R Ashfaq, K Walter, K Berg, SE Kern, MG Goggins, RH Hruban, CA Iacobuzio-Donahue
Johns Hopkins Hospital, Baltimore, MD; UT Southwestern Medical Center, Dallas, TX
|
|
|
